Premium
Fetal RHD genotyping is a cost‐effective option for supporting targeted anti‐D prophylaxis in D‐negative pregnancies
Author(s) -
Allard S,
Massey E
Publication year - 2018
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.15259
Subject(s) - nice , medicine , genotyping , population , obstetrics , cost effectiveness , pregnancy , gynecology , genotype , risk analysis (engineering) , biochemistry , chemistry , environmental health , computer science , gene , programming language , genetics , biology